Downstream Processing Featured Articles

  1. New Cell Type Developed For Possible Treatment Of Alzheimer's And Other Brain Diseases 11/7/2012

    UC Irvine researchers have created a new stem cell-derived cell type with unique promise for treating neurodegenerative diseases such as Alzheimer’s.

  2. Pittcon 2013 Conference Tackles Life Sciences Challenges, Novel Research 2/7/2013

    Pittcon has always been the premiere venue for companies to launch new products and for scientists to present their latest research to a global audience.

  3. Unraveling The Molecular Roots Of Down Syndrome 3/24/2013

    What is it about the extra chromosome inherited in Down syndrome—chromosome 21—that alters brain and body development? Researchers have new evidence that points to a protein called sorting nexin 27, or SNX27.

  4. Roche Receives FDA Clearance For Herpes Simplex Virus Type 1 And 2 Tests 9/4/2012

    Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its IgG Antibody to herpes simplex virus (HSV) types 1 and 2 assays for use on cobas® modular platforms. The tests are intended for use with sexually active individuals and expectant mothers as an aid in the presumptive diagnosis of HSV-1 and HSV-2 infection. 

  5. Therapure Announces Opening Of Custom Biologics Manufacturing Wing 4/20/2012

    Recently marked the official opening of Therapure Biopharma Inc.’s Custom Biologics Manufacturing Wing, which supports the development and manufacture of innovative medical treatments.

  6. Hamilton Robotics Launches Highly Flexible PCR Setup Workstation 3/18/2013

    Hamilton Robotics introduces the PCR setup STARlet, the first automated liquid handling system flexible enough to accommodate any DNA amplification reagent kit, from simple setups and small budgets to highly demanding workflows.

  7. Researchers Develop Method To Grow Artificial Tissues With Embedded Nanoscale sensors 8/26/2012

    A multi-institutional research team has developed a method for embedding networks of biocompatible nanoscale wires within engineered tissues. These networks—which mark the first time that electronics and tissue have been truly merged in 3D—allow direct tissue sensing and potentially stimulation, a potential boon for development of engineered tissues that incorporate capabilities for monitoring and stimulation, and of devices for screening new drugs.

  8. Single-Use Devices — What's REALLY Holding Up Adoption? 8/1/2011

    Today, single-use products have pushed beyond early-stage applications. However, single-use devices still need to address a number of problems in GMP commercial-scale operations. By Eric Langer, president and managing partner, BioPlan Associates, Inc.

  9. Aeras Signs Agreement With GSK To Jointly Advance TB Vaccine 10/10/2012

    Aeras announces that it has signed an agreement with GlaxoSmithKline Vaccines, S.A. (GSK) to jointly advance the clinical development of an investigational tuberculosis (TB) vaccine containing GSK’s proprietary M72 antigen and AS01E adjuvant.

  10. Skystar's New Vaccine Facility In Huxian Passes Initial GMP Certification 11/13/2012

    Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced that China's Ministry of Agriculture (MOA) Good Manufacturing Process "GMP" experts have certified that Skystar's new vaccine facility in Huxian, China is 'Stage 1' GMP compliant.